Patent · US Active

Multicomponent crystalline system comprising deferasirox and isonicotinamide and a process for the preparation thereof

US9290452B2 · kind B2 · utility

2Cited by

0References

10Claims

0Family size

Assignee

BASF SE

Inventors

Andreas Hafner · Gelterkinden, CH
Fritz Blatter · Reinach, CH
Eva Roedel · Basel, CH
Martin Szelagiewicz · Münchenstein, CH
Tiziana Chiodo · Mannheim, DE
Tobias Hintermann · Therwil, CH
Beate Salvador · Ellerstadt, DE
Marcus Vossen · Schifferstadt, DE

Key dates

Filing date	Aug 5, 2013
Grant date	Mar 22, 2016
Priority date	—
Expiry date	Aug 5, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/13
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention refers to a multicomponent crystalline system (co-crystal) comprising a compound of formula (1) (4-[3,5-Bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl]benzoic acid; INN: Deferasirox) formula (1) and a compound of formula (2) (Isonicotinamide; pyridine-4-carboxamide) formula (2), as well as to a process for obtaining the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.